Late-onset Hypogonadism and Testosterone Therapy – A Summary of Guidelines from the American Urological Association and the European Association of Urology
Articolo
Data di Pubblicazione:
2019
Abstract:
The benefits and risks of testosterone therapy are controversial, and ambiguities surround testosterone therapy in practice. This is reflected in the European Association of Urology and American Urological Association guidelines, as these differ on several points of management.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Androgens; Erectile dysfunction; Hypogonadism; Libido; Lifestyle; Major cardiac adverse event; Prostate cancer; Sexual desire; Testosterone; Testosterone deficiency; Testosterone replacement therapy; Adult; Age of Onset; Humans; Hypogonadism; Male; Testosterone
Elenco autori:
Fode, M.; Salonia, A.; Minhas, S.; Burnett, A. L.; Shindel, A. W.
Link alla scheda completa:
Pubblicato in: